Cargando…
Glioblastoma multiforme: State of the art and future therapeutics
BACKGROUND: Glioblastoma multiforme (GBM) is the most common and lethal primary malignancy of the central nervous system (CNS). Despite the proven benefit of surgical resection and aggressive treatment with chemo- and radiotherapy, the prognosis remains very poor. Recent advances of our understandin...
Autores principales: | Wilson, Taylor A., Karajannis, Matthias A., Harter, David H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4078454/ https://www.ncbi.nlm.nih.gov/pubmed/24991467 http://dx.doi.org/10.4103/2152-7806.132138 |
Ejemplares similares
-
The Landscape of Novel Therapeutics and Challenges in Glioblastoma Multiforme: Contemporary State and Future Directions
por: Khaddour, Karam, et al.
Publicado: (2020) -
Glioblastoma Multiforme: Novel Therapeutic Approaches
por: Fialho, Arsenio M., et al.
Publicado: (2012) -
Drug Delivery Nanosystems in Glioblastoma Multiforme Treatment: Current State of the Art
por: Di Filippo, Leonardo Delello, et al.
Publicado: (2021) -
Glioblastoma Multiforme: An Overview of Emerging Therapeutic Targets
por: Taylor, Olivia G., et al.
Publicado: (2019) -
Surgical Treatment of Glioblastoma: State-of-the-Art and Future Trends
por: Sales, Arthur H. A., et al.
Publicado: (2022)